| 导语 | |
| 栏目一 | |
| 栏目二 | |
| 栏目三 | |
| 栏目四 | |
| 栏目五 | |
| 背景图片 | 无图片信息！ |
| 设计 | |
| 策划 | |
| 正文 |
Question：You are the auditor of Nenox, a large public limited pharmaceuticals manufacturer. The audit is complex and high profile and it is particularly important that non-sampling risk is minimised.
Which of the following would have no effect on non-sampling risk?
A. Review the audit working papers more frequently.
B. Produce a detailed planning memorandum.
C. Use more experienced staff.
D. Increase the number of items selected for detailed testing.
The correct answer is: D
Increasing the number of items selected for detailed testing will impact on sampling risk but will have no effect on non-sampling risk.
The other three choices will have the effect of reducing non-sampling risk.
|
相关热点：
上一篇：上一篇：如何应对ACCA考试中的难题？
下一篇：下一篇：2016ACCA P5习题：Current developments
